411 related articles for article (PubMed ID: 9672063)
1. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.
Lijnen HR; Van Hoef B; Lupu F; Moons L; Carmeliet P; Collen D
Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1035-45. PubMed ID: 9672063
[TBL] [Abstract][Full Text] [Related]
2. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
[TBL] [Abstract][Full Text] [Related]
3. Role of the fibrinolytic and matrix metalloproteinase systems in arterial neointima formation after vascular injury.
Lijnen HR
Verh K Acad Geneeskd Belg; 2001; 63(6):605-22. PubMed ID: 11813512
[TBL] [Abstract][Full Text] [Related]
4. Synergy between a plasminogen cascade and MMP-9 in autoimmune disease.
Liu Z; Li N; Diaz LA; Shipley M; Senior RM; Werb Z
J Clin Invest; 2005 Apr; 115(4):879-87. PubMed ID: 15841177
[TBL] [Abstract][Full Text] [Related]
5. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.
Lund LR; Green KA; Stoop AA; Ploug M; Almholt K; Lilla J; Nielsen BS; Christensen IJ; Craik CS; Werb Z; Danø K; Rømer J
EMBO J; 2006 Jun; 25(12):2686-97. PubMed ID: 16763560
[TBL] [Abstract][Full Text] [Related]
7. Stromelysin-1 (MMP-3)-independent gelatinase expression and activation in mice.
Lijnen HR; Silence J; Van Hoef B; Collen D
Blood; 1998 Mar; 91(6):2045-53. PubMed ID: 9490689
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen and plasmin activity in patients with coronary artery disease.
Drinane MC; Sherman JA; Hall AE; Simons M; Mulligan-Kehoe MJ
J Thromb Haemost; 2006 Jun; 4(6):1288-95. PubMed ID: 16706973
[TBL] [Abstract][Full Text] [Related]
9. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract][Full Text] [Related]
10. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
[TBL] [Abstract][Full Text] [Related]
11. Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis.
Brodsky S; Chen J; Lee A; Akassoglou K; Norman J; Goligorsky MS
Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1784-92. PubMed ID: 11557572
[TBL] [Abstract][Full Text] [Related]
12. Different mechanisms of increased luminal stenosis after arterial injury in mice deficient for urokinase- or tissue-type plasminogen activator.
Schäfer K; Konstantinides S; Riedel C; Thinnes T; Müller K; Dellas C; Hasenfuss G; Loskutoff DJ
Circulation; 2002 Oct; 106(14):1847-52. PubMed ID: 12356640
[TBL] [Abstract][Full Text] [Related]
13. Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice.
Carmeliet P; Moons L; Dewerchin M; Rosenberg S; Herbert JM; Lupu F; Collen D
J Cell Biol; 1998 Jan; 140(1):233-45. PubMed ID: 9425170
[TBL] [Abstract][Full Text] [Related]
14. Staphylokinase reduces plasmin formation by endogenous plasminogen activators.
Jin T; Bokarewa M; Zhu Y; Tarkowski A
Eur J Haematol; 2008 Jul; 81(1):8-17. PubMed ID: 18331597
[TBL] [Abstract][Full Text] [Related]
15. Plasmin is not protective in experimental renal interstitial fibrosis.
Edgtton KL; Gow RM; Kelly DJ; Carmeliet P; Kitching AR
Kidney Int; 2004 Jul; 66(1):68-76. PubMed ID: 15200414
[TBL] [Abstract][Full Text] [Related]
16. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade.
Baricos WH; Cortez SL; el-Dahr SS; Schnaper HW
Kidney Int; 1995 Apr; 47(4):1039-47. PubMed ID: 7540230
[TBL] [Abstract][Full Text] [Related]
17. Vascular extracellular matrix remodeling in cerebral aneurysms.
Bruno G; Todor R; Lewis I; Chyatte D
J Neurosurg; 1998 Sep; 89(3):431-40. PubMed ID: 9724118
[TBL] [Abstract][Full Text] [Related]
18. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells.
Ginestra A; Monea S; Seghezzi G; Dolo V; Nagase H; Mignatti P; Vittorelli ML
J Biol Chem; 1997 Jul; 272(27):17216-22. PubMed ID: 9202045
[TBL] [Abstract][Full Text] [Related]
19. Reduced transplant arteriosclerosis in plasminogen-deficient mice.
Moons L; Shi C; Ploplis V; Plow E; Haber E; Collen D; Carmeliet P
J Clin Invest; 1998 Nov; 102(10):1788-97. PubMed ID: 9819364
[TBL] [Abstract][Full Text] [Related]
20. Investigations on the Role of the Fibrinolytic Pathway on Outflow Facility Regulation.
Hu Y; Barron AO; Gindina S; Kumar S; Chintala S; Nayyar A; Danias J
Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1571-1580. PubMed ID: 30995314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
